Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
64.78
-1.18 (-1.79%)
Aug 20, 2026, 11:03 AM EDT - Market open
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $6.11 billion as of August 20, 2026. Its market cap has increased by 288.56% in one year.
Market Cap
6.11B
Enterprise Value
6.23B
1-Year Change
288.56%
Ranking
Category
Stock Price
$64.78
ChartMarket Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $6.11B, an increase of 15,014.44%. That is a compound annual growth rate of 44.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 6.11B | 78.61% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.79B |
| Mirum Pharmaceuticals | 6.64B |
| Caris Life Sciences | 6.43B |
| Cogent Biosciences | 6.40B |
| Dianthus Therapeutics | 6.36B |
| Erasca | 6.32B |
| Definium Therapeutics | 6.16B |
| PTC Therapeutics | 6.15B |